You are viewing the site in preview mode

Skip to main content

Table 2 Changes in the Hamilton Anxiety Rating Scale (HAM-A) over time in both the ketamine and buprenorphine groups

From: Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity

HAM-A scores (mean ± SD)

Ketamine

Buprenorphine

Baseline

26.67 ± 8.711

24.77 ± 8.838

2 h later

11.97 ± 9.492

9.167 ± 8.762

24 h later

8.667 ± 8.180

6.467 ± 5.734

7 days later

6.533 ± 5.387

5.633 ± 6.419

Back to article page

Trials

ISSN: 1745-6215